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Abstract 
Introduction: Transcutaneous Bilirubinometry (TcB) is a simple method for estimating bilirubin levels in neonates. 
This method is non-invasive, quick, and painless. We aimed to compare serum and cutaneous bilirubin 
measurements in term neonates.Materials and Methods:In this descriptive cross-sectional study, 230 neonates with 
icterus and birth weights of at least 2,500 grams or more were studied. TcB was measured using a bilirubinometer 
three times on the forehead and mean levels were calculated. Then, during the subsequent 30 minutes blood samples 
were obtained and sent to the laboratory for determining the Total Serum Bilirubin (TSB) levels.Results:Of the 230 
neonates, 124 (62%) were boys and 76 (38%) were girls, with aMean± SD (Standard Deviation) age of 5.3±4.5 to 
5.1+3.5 days   (range:   1-22   days).   99%   of  the neonates were breastfed and 49(21.30%) neonates had a history 
of icterus. Most of the neonates were the first child (53.90%). Moreover, 32.60% were the second child, and 13.50% 
were the third child and the next. 12.17%,13.91%, 13.91%,60.43% of the neonates became icteric on days 1, 2, 3, 
and 4 or more of birth respectively. Most neonates with hyperbilirubinemia have B+ blood(53.90) group and then 
A+ blood group(34.78%) have the highest frequency in the study. O+ blood group in mothers of newborns with 
jaundice was the most common (53.04 %), and then B+ blood group have the highest frequency in the mothers 
(25.65%). The mean ± SD serum and cutaneous bilirubin levels were 18.70±5.33 and 17.75±4.26 mg/dl, 
respectively. A high correlation (0.84) was observed between TSB and TcB.Conclusion:There was a strong 
correlation between serum and transcutaneous bilirubin levels. As transcutaneous bilirubin estimation is non-
invasive, it gives quick and reproducible results. So, this method has potential screening value especially in the 
high-risk neonates for early intervention. 
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Introduction 
 
Neonatal hyperbilirubinemia is a common problem 
with incidence of around 60% in term babies and 
nearly 80- 100% in preterm babies. The bilirubin level 
above 95th percentile may lead to acute bilirubin 
encephalopathy and or kernicterus which also has long 
term morbidity in form of cerebral palsy.[1,2 ]This 
complication is preventable through early recognition, 
appropriate follow up and treatment such as 
phototherapy and exchange transfusion.[2-6]  
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The AAP guideline recommends assessment of 
jaundice in all newborns before hospital discharge. 
However, the method by which jaundice must be 
assessed is not specified. Both transcutaneous bilirubin 
(TcB) and total serum bilirubin (TSB) measurements 
are cited as acceptable method.[5] TSB measurement 
is still considered the gold standard. But it is invasive, 
painful and costly in terms of workload, time and 
money. Moreover, there is a concern of significant 
blood loss due to repeated sampling especially in 
preterms. TcB being a noninvasive method can 
overcome these problems.[7,8] Studies have shown 
good correlation between TSB and TcB in various 
ethnic groups by various authors. However, correlation 
was affected by various factors like race, gestational 
age, birth weight, skin color, type of TcB 
instrument.[9-13]Considering the importance of this 
issue and the inconsistencies betweenprevious studies 
regarding the accuracy of TcB, we aimed to compare 
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the relationship between TcB and TSB measurements 
in term neonates. Moreover, we also studied the 
sensitivity and specificity of TcB based on the age of 
the neonates and bilirubin levels. 
Materials and Methods 
This was an observational cross-sectional study to 
compare serum and transcutaneous bilirubin 
measurements in newborns by measuring serum 
bilirubin level and transcutaneous bilirubinometer 
level who was admitted  at neonatal intensive care unit 
of Nalanda Medical College and Hospital, Patna, Bihar 
India.The study was carried out for the period of 1 
year. 
Inclusion criteria 
Hyperbilirubinemia  
Those willing to participate  
Exclusion criteria 
Neonate with sepsis,  
Direct hyperbilirubinemia,  
Major congenital anomaly,  
Hemangioma or ecchymosis on the forehead,  
Previous phototherapy, birth asphyxia, skin diseases  
Data collection -Data was collected using pre-tested 
semi structured proforma. Neonatal data collected 
including age, sex, birth weight, current weight, 
length, onset of jaundice, birth order in the family, 
history of jaundice in the family, type of feeding, 
history of hospitalization, neonatal and maternal blood 
group, history of phototherapy. Previous 
measurements in serum and skin bilirubin, history of 
blood transfusion in new-born, and maternal prenatal 
care. Sample for both bilirubin levels reading serum 
and transcutaneous were taken simultaneously. Blood 
samples were obtained from neonates collected from 
venous sample into plainbulb.The samples were 
immediately sent to the hospital laboratory where the 
serum was separated and then immediately assayed for 
bilirubin by a DIAZO method which involves reacting 
serum with diazo reagent and then through 
spectrophotometry the levels of direct and indirect 
bilirubin were determined. Transcutaneous bilirubin 
level measurement was done by a single 
transcutaneous bilirubinometer used throughout the 
study period. The optic head of the meter is gently 
pressed against the neonate’s skin (usually forehead or 
upper part of the sternum). For correct measurement, 
the optic head should make full contact with the skin 
and there should be no gaps between the head and the 
skin. This should be achieved by gentle pressure. The 
reading from forehead and sternum were measured and 
an average reading taken for comparison. After taking 
first reading babies were kept on phototherapy and 
patch cover of an area approximately 1.5 cm2were 
applied over forehead and sternum and a second 
reading was taken after 24 hour and third reading 
thereafter by the same way. 
Results 
Of the 230 neonates, 124 (62%) were boys and 76 
(38%) were girls, with aMean±SD (Standard 
Deviation) age of 5.3±4.5 5.1+3.5 days   (range:   1-22   
days).   99%   of  the neonates were breastfed and 
49(21.30%) neonates had a history of icterus. The 
mean±SDweights of the neonates were 3001±339 
grams. Most of the neonates were the first child 
(53.90%). Moreover, 32.60% were the second child, 
and 13.50% were the third child and the next. 12.17%, 
13.91%, 13.91%, 60.43% of the neonates became 
icteric on days 1, 2, 3, and 4 or more of birth 
respectively (Table.1).No significant relationship was 
observed between serum and cutaneous bilirubin and 
history of jaundice in the family. Moreover, no 
significant relationship was found between type of 
delivery and hyperbilirubinemia. In this study, no 
significant relationship was observed between history 
of hospitalization and serum and cutaneous bilirubin. 
Moreover, no significant relationship was found 
between nutrition and serum and  cutaneousbilirubin. 
Most neonates with hyperbilirubinemia have B+ 
blood(53.90%) group and then A+ blood 
group(34.78%) have the highest frequency in the 
study. O + blood group in mothers of newborns with 
jaundice was the most common ( 53.04 % ), and then 
B+ blood group have the highest frequency in the 
mothers ( 25.65%).(table 2,3) We also assessed the 
sensitivity and specificity of different TcB 
measurements. Table.4 shows the sensitivity and 
specificity of this method for different bilirubin levels. 
As shown, the highest specificity and sensitivity was 
related to bilirubin levels between 12-15 mg/dl. The 
mean ± SD serum and cutaneous bilirubin levels were 
18.70±5.33 and 17.75±4.26 mg/dl, respectively. A 
high correlation (0.84) was observed between TSB and 
TcB. Table.5 shows the frequency and percentage of 
serum bilirubin as compared with cutaneous bilirubin 
in normal and abnormal states for calculating positive 
and negative predictive values of cutaneous bilirubin 
based on serum bilirubin. In this table bilirubin levels 
below 12 are considered normal. In this study the 
positive and negative predictive values of TcB were 
92.63%and 70%. We also calculated the sensitivity 
and specificity 
Table 1: Frequency distribution of different study variables 
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Variables N % age 
Gender  
Male 144 62.60 
Female 86 37.39 
Weight (grams)  
2500-3000 137 59.56 
3001-3500 71 30.86 
≥3500 22 9.56 
History of icter  
Yes 49 21.30 
No 181 78.69 
Birth Order  
First 124 53.91 
Second 75 32.60 
Third or more 31 13.47 
 
Table 2: Blood groups of the mothers 
 
Mother blood group No. of mothers % age  
A+ve 31 13.47 
B+ve 59 25.65 
AB+ve 9 3.91 
O+ve 122 53.04 
A-ve 3 1.30 
B-ve 1 0.43 
O-ve 5 2.17 
 
Table 3: Blood groups of the patients/new-borns 
 
Newborn blood group No. of mothers % age  
A+ve 80 34.78 
B+ve 124 53.91 
AB+ve 6 2.60 
O+ve 16 6.9 
A-ve 4 1.73 
 
Table 4: Specificity and sensitivity of cutaneous bilirubin measurement based on bilirubin levels 
Bilirubin Levels (mg/dl) Specificity (%) Sensitivity (%) 
<8 25 100 
8-12 25 94.5 
12-15 100 96.2 
≤15 80 96 
 
Table 5: Frequency and percentage of Serum bilirubin versus cutaneous bilirubin 
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Cutaneous bilirubin 
Serumbilirubin Total 
Abnormal Normal  
Abnormal
*
 176 (92.63%) 14 (7.37%) 190 (100.0%) 
Normal 12 (30%) 28 (70%) 40 (100.0%) 
           Total 188 (81.74%) 42 (18.26%) 230 (100.0%) 
* Bilirubin levels above 12 (mg/dl) are considered abnormal 
Table 6: Sensitivity and Specificity of TcB measurements with respect to age 
Age Bilirubin Mean±SD(mg/dl) Specificity(%) Sensitivity (%) 
One day 
Cutaneous 10.5±2.33 
25 100 
Serum 10.5±2.48 
Two days 
Cutaneous 15.42±3.29 
25 95 
Serum 15.11±3.43 
Three days 
Cutaneous 17.11±2.49 
100 92 
Serum 18.71±3.99 
Four or More days 
Cutaneous 19.2±3.33 
80 96 
Serum 18.71±4.10 
Discussion 
We found a high correlation between TcB and TSB 
measurements in neonates (r=0.84). Consistently, in 
another study on 490 neonates over 2.5 kg a high 
correlation (r=0.91) was observed between TcB and 
TSB[14]. Several studies have been done in this 
regard[15-18].One study on 388 healthy term neonates 
showed a correlation coefficient of 0.8; which is very 
similar to our study[18]. In another study on 490 
neonates with a gestational age of more than 35 weeks, 
a correlation coefficient of 0.91 was  
 
 
 
observed[14].Briscoe and colleagues also found a 
correlation coefficient of 0.76 by studying 285 
neonates[19]. Minor differences between the 
mentioned studies could be attributed to differences in 
the type of bilirubinometers, skin color, ethnicity, 
laboratory methods and kits, etc.We found that TcB 
had a high specificity for bilirubin levels over 12  
 
mg/dl, especially for levels between 12-17 mg/dl. For 
levels lower than 12 mg/dl, its specificity decreased 
while its sensitivity increased; therefore, increasing the 
number of false positives. Also, for levels higher than 
17 mg/dl, false negative cases would increase. In a 
study on 200 Brazilian neonates, higher correlations 
between TSB and TcB measurements were observed 
for bilirubin levels lower than 14 mg/dl. The 
researchers concluded that for levels over 14 mg/dl, 
serum measurements should be done[20]. Few studies 
have been done on specificity and sensitivity based on 
birth age, and most studies have calculated the 
sensitivity and specificity of TcB based on gestational 
age, sex, ethnicity, and weight. However, we also 
evaluated the former variable in our study.Day one and 
day two TcB yielded low specificity and high 
sensitivity. Therefore, during these days,  false positive 
cases would increase and the accuracy of TCB would 
decrease. From day three onward false positive cases 
would decrease considering its higher specificity and 
accuracy would rise. Therefore, TcB measurements are 
closer to TSB measurements on days three and 
four.Our results are relatively comparable with another 
recent study in Italy that showed a significant increase 
in the specificity of bilicheck 61-96 hours after birth 
compared with 0-60 hours (P=0.074). However, the 
mentioned study did not assess the sensitivity of 
bilicheck as well as its specificity after 96 hours from 
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birth[21].In a study on 560 neonates, a good 
correlation was found between TcBand TSB after 24 
hours from birth. However, the mentioned study did 
not evaluate the association between TcB and TSB on 
the first day of birth. The specificity and sensitivity of 
bilicheck was also not assessed[22]. The highest levels 
of bilirubin are seen on the fifth and sixth days of 
birth. This is while most neonates are discharged 48 
hours after birth. Therefore, they should be followed 
accurately with respect to icterafterdischarge. 
However, because of its relatively low specificity, in 
this study we emphasize that in neonates with 
progressive jaundice, those with risk factors such as 
hemolysis or infection, or those with higher than 
normal bilirubin levels detected by TcB, serum 
bilirubin levels must be checked. With respect to the 
effect of gestational age on the correlation between 
TcB and TSB, De Luca and colleagues reported a 
correlation coefficient of 0.79 and confirmed a lower 
correlation coefficient in term neonates as compared 
with premature ones[23]. On the other hand, other 
researchers found that the correlation coefficient 
between TcB and TSB increase as the gestational age 
increases (from 0.43 for 23-28 weeks to o.72 for 
35036 weeks)[24]. Douville et al., also found an 
excellent correlation between TcBand TSB in term 
neonates as compared with premature ones[25]. 
Further research is needed in this regard. In our study, 
we did not consider gestational age since all neonates 
wereterm 
Conclusion 
We found a high correlation between TcB and TSB 
measurements in term neonates. Due to its simplicity 
and painlessness, serial cutaneous bilirubin 
measurements would be helpful in following neonatal 
icterus. Although TcB has a high sensitivity in 
detecting icter, it should not replace TSB due to its 
relatively low specificity. Therefore, in high risk 
neonates, measuring TSB alongside TcB isnecessary. 
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